Summary of Key Information:
Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI (LODR) Regulations, 2015
Corporate Actions:
The Board of Directors approved the "Aarti Drugs Limited Performance Stock Option Plan 2026" (PSOP 2026).
The plan involves creating and granting not exceeding 8,00,000 (Eight lakh) Performance Stock Options.
These options are convertible into an equal number of equity shares of face value of ₹10 each.
The grants are intended for eligible employees as per SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The plan implementation is subject to approval by the Members of the Company.
Other Significant Information:
Reference Number: ADL/SE/2026-27/40
Dated: August 27, 2026